In Brief TORC1 signaling promotes protein translation and cellular aging. Rodríguez-Ló pez et al. show that this role of TORC1 is partly mediated via the transcription factor Gaf1. When TORC1 is blocked, Gaf1 extends the cellular lifespan by inhibiting the transcription not only of protein-coding genes but also of tRNA genes functioning in translation. Target of Rapamycin Complex 1 (TORC1) signaling promotes growth and aging. Inhibition of TORC1 leads to reduced protein translation, which promotes longevity. TORC1-dependent post-transcriptional regulation of protein translation has been well studied, while analogous transcriptional regulation is less understood. Here we screen fission yeast mutants for resistance to Torin1, which inhibits TORC1 and cell growth. Cells lacking the GATA factor Gaf1 (gaf1D) grow normally even in high doses of Torin1. The gaf1D mutation shortens the chronological lifespan of non-dividing cells and diminishes Torin1-mediated longevity. Expression profiling and genome-wide binding experiments show that upon TORC1 inhibition, Gaf1 directly upregulates genes for small-molecule metabolic pathways and indirectly represses genes for protein translation. Surprisingly, Gaf1 binds to and downregulates the tRNA genes, so it also functions as a transcription factor for RNA polymerase III. Thus, Gaf1 controls the transcription of both protein-coding and tRNA genes to inhibit translation and growth downstream of TORC1.
INTRODUCTION
The conserved Target of Rapamycin (TOR) signaling pathway is a key regulator for cellular growth and metabolism in response to nutrients and energy (Gonzalez and Rallis, 2017; Gonzá lez and Hall, 2017; Valvezan and Manning, 2019; Wei et al., 2013) . TOR generally functions via two multi-protein complexes, TORC1 and TORC2, which coordinate distinct aspects of growth and associated processes (Hartmuth and Petersen, 2009; Ikai et al., 2011) . TORC2 is not required for cell proliferation in fission yeast (Schizosaccharomyces pombe) but is required for sexual differentiation, stress response, and actin function (Matsuo et al., 2007; Weisman and Choder, 2001) . TORC1 activates protein synthesis and other anabolic processes and inhibits autophagy and other catabolic processes. Active TORC1 functions on lysosomes, or vacuoles in yeast, in response to growth signals (Binda et al., 2009; Chia et al., 2017; Po€ us and Codogno, 2011; Valbuena et al., 2012) . In all organisms tested, TORC1 promotes aging and shortens lifespan (Gonzalez and Rallis, 2017; Gonzá lez and Hall, 2017; Kaeberlein, 2010; Wei et al., 2013) . Lifespan is influenced by multiple TORC1-dependent processes, including mitochondrial activity (Hill and Van Remmen, 2014) , autophagy (Saxton and Sabatini, 2017) , and protein translation (Bjedov and Partridge, 2011; . Protein translation is controlled posttranscriptionally by TORC1 via phosphorylation of ribosomal S6 kinase (S6K) and the translation factors eIF2a and 4E-BP (Ma and Blenis, 2009 ). Inhibition of S6K can extend lifespan in several organisms (Bjedov et al., 2010; Rallis et al., 2014; Roux et al., 2006; Selman et al., 2009) .
Besides post-transcriptional mechanisms, TORC1 promotes translational capacity and aging via transcriptional regulation (Valvezan and Manning, 2019) . It stimulates transcription of ribosomal RNAs via RNA polymerases I and III (RNA Pol I and RNA Pol III) (Iadevaia et al., 2014) , although mechanisms are poorly understood. TORC1 may regulate RNA Pol I transcription via general transcription factors (Hannan et al., 2003; Mayer et al., 2004) . TORC1 also regulates the conserved Maf1 factor, which inhibits RNA Pol III (Cai and Wei, 2015; Graczyk et al., 2018; Michels et al., 2010; Shor et al., 2010; Wei and Zheng, 2010; Wei et al., 2009) . RNA Pol III transcribes the highly abundant 5S ribosomal RNAs and transfer RNAs (tRNAs), which are central for translation, besides other small RNAs (Arimbasseri and Maraia, 2016) . Given the focus on protein-coding gene transcription, the regulation of RNA Pol III transcription is less well understood. A recent study shows that RNA Pol III activity limits the lifespan downstream of TORC1 (Filer et al., 2017) . Altogether, these findings suggest that TORC1-mediated control of RNA Pol III transcription is universally important for translation and aging. However, no specific transcription factors have been identified that bind to RNA Pol III-dependent promoters and thus mediate translational control and lifespan.
The conserved S. pombe GATA transcription factor Gaf1 regulates responses to nitrogen limitation downstream of TORC1 (Laor et al., 2015) . Gaf1 can regulate gene expression either positively or negatively (Kim et al., 2012) . Here we show that Gaf1 is required for growth suppression upon TORC1 inhibition. Gaf1 binds not only to the promoters of certain protein-coding genes but also to the RNA Pol III-transcribed tRNA genes, which leads to their repression. Mutant cells lacking Gaf1 feature a shortened chronological lifespan. Our results uncover a transcription factor downstream of TORC1 that directly inhibits transcription of the tRNA genes, providing a mechanism for transcriptional control of global protein translation that prolongs lifespan.
RESULTS AND DISCUSSION
Genes Required for TOR-Mediated Growth Inhibition TORC1 and TORC2 can be inhibited by Torin1, an ATP analog that blocks cell proliferation in S. pombe (Atkin et al., 2014; Thoreen et al., 2009 ). Using a low Torin1 dose (5 mM), S. pombe mutants have been screened for resistance and sensitivity to reduced TOR signaling (Lie et al., 2018) . Here we screened mutants under a four-fold higher Torin1 dose (20 mM). This dose blocked cell growth ( Figure 1A ) and reduced the size of both cells and vacuoles ( Figure 1B ). Global protein translation was also reduced by Torin1, as reflected by reduced phosphorylation of ribosomal S6 protein and increased total and phosphorylated eIF2a ( Figure 1C ). Altogether, these phenotypes look like those triggered by caffeine and rapamycin that block TORC1 function . We conclude that Torin1 leads to phenotypes that are diagnostic for TORC1 inhibition.
We screened for deletion mutants that can suppress the strong growth inhibition by 20 mM Torin1 ( Figure 1D ). Overall, 19 mutants were resistant to Torin1-mediated growth inhibition in all 4 repeats ( Figure 1E ; Table S1 ), 9 of which were identified in the previous screen (Lie et al., 2018) . We independently validated these 19 mutants, both by PCR and by backcrossing to a wild-type strain. The backcrossed mutants were spotted on Torin1 plates to confirm linkage of the drug-resistant phenotype to the deletion cassette. Although wild-type cells did not grow in Torin1, all 19 mutants managed to grow to various extents in different concentrations of Torin1 ( Figure 1F ). Four mutants were resistant to Torin1 at all concentrations, showing similar growth as on untreated medium ( Figure 1F , red frames).
Some mutants feature resistance to multiple rather than specific drugs (Dawson et al., 2008) . To exclude this possibility for the Torin1-resistant mutants, we assayed their growth in four other drugs; this analysis showed that all mutants were at least as sensitive to the other drugs as the wild-type control (Figure S1A) , indicating that their Torin1 resistance does not reflect multi-drug resistance. To exclude the possibility that resistance simply reflects that mutants cannot take up Torin1, we tested whether the Torin1-resistant mutants still showed other phenotypes of TORC1 inhibition ( Figures 1B and 1C ). The mutants still showed reduced ribosomal S6 protein phosphorylation after Torin1 treatment, except aca1D ( Figure S1B ), and decreased cell size ( Figure S1C ). These results indicate that Torin1 is taken up by the mutant cells, which differ in sensitivity to different TORC1 functions. Moreover, in all but the aca1D mutant, the growth resistance to Torin1 may be independent of translational control by ribosomal S6 phosphorylation.
The 19 genes identified in our screen function in limited cellular processes ( Figure 1G ; Table S1 ). Vesicular transport and vacuolar functions were associated with 13 genes, 6 of which encode components of endosomal sorting complexes required for transport (ESCRT). Many of these proteins are part of the Nbr1-mediated vacuolar targeting (NVT) autophagic system . The NVT pathway does not contain core Atg proteins but depends on ESCRTs and the multi-vesicular body to deliver soluble cargoes to the vacuole. How might vesicular transport and the NVT pathway relate to TOR signaling? Disruption of vesicle-mediated transport at the endosome triggers a metabolic signature similar to TORC1 inhibition (Mulleder et al., 2016) . It is possible that TORC1 controls the NVT pathway or that some of our mutants affect TORC1 localization to the vacuole, thus rendering the system resistant to Torin1 inhibition. A gene from the screen encodes the GATA transcription factor Gaf1. In budding yeast, components of Golgi-to-vacuole trafficking are required for TORC1-responsive regulation of GATA factors (Fayyadkazan et al., 2014; Puria et al., 2008) . Given our interest in TORC1-dependent gene regulation and the strong Torin1-resistance of gaf1D mutants ( Figure 1G ), we further analyzed the function of Gaf1.
Gaf1 Is Required for Normal Lifespan and Lifespan Extension by Torin1 Treatment TORC1 inhibition through nutrient limitation or rapamycin prolongs chronological lifespan in S. pombe (Rallis et al., , 2014 , defined as the time post-mitotic cells remain viable in stationary phase. Given that Gaf1 is required to arrest growth upon TOR inhibition, we hypothesized that Gaf1 may also play a role in chronological lifespan. Indeed, gaf1D cells were shorter lived, with median and maximum lifespans of 3 and 16 days, respectively, compared with 5 and 20 days for wild-type cells ( Figure 2 ). Thus, Gaf1 is required for the normal lifespan of non-dividing cells.
Torin1 increases lifespan in flies (Mason et al., 2018) and suppresses senescence in human tissue cultures (Leontieva and Blagosklonny, 2016) . To analyze the effect of Torin1 on chronological lifespan in S. pombe, and any role of Gaf1 in this condition, we pre-treated exponentially growing wild-type and gaf1D cells with Torin1 and tested for subsequent effects on lifespan during the stationary phase. Torin1 substantially prolonged lifespan in wild-type cells, with median and maximum lifespans of 18 and 33 days, respectively, compared with 5 and 20 days in untreated cells (Figure 2A ). In gaf1D cells, Torin1 also prolonged lifespan but to a lesser extent than in wild-type cells, with median and maximum lifespans of $13 and 30 days, respectively (Figure 2A) . To quantify the role of Gaf1 in Torin1-mediated longevity, we calculated the areas under the curve (AUCs, measured as days 3 percentage of survival from lifespan assays). In wild-type cells, the lifespan was prolonged from an average AUC of 1,044 to 2,689 (increase of 1,645), whereas in gaf1D cells, the lifespan was prolonged to a lesser extent, from an average AUC of 681 to 1,709 (increase of 1,027) ( Figure 2B ). We conclude that Gaf1 is also required for the full lifespan extension resulting from Torin1-mediated TOR inhibition during cell proliferation. However, Torin1 still can prolong lifespan considerably without Gaf1, indicating that other factors contribute to this longevity. Indeed, we have identified several proteins required for lifespan extension when TORC1 is inhibited, including the S6K protein Sck2 (Rallis et al., 2014) .
Gaf1-Dependent Transcriptome Regulation following TOR Inhibition
Given that Gaf1 was essential for growth inhibition by Torin1 (Figure 1G) , we further analyzed its function in this condition. Gaf1 (D) Design of genome-wide screens to identify mutants resistant to Torin1-mediated growth inhibition. We screened Bioneer version 2 (3,005 mutants) and Bioneer version 5 (3,420 mutants) of deletion libraries (Kim et al., 2010) in two independent repeats each, using 20 mM Torin1 on rich solid medium (YES).
(E) Example of deletion library plate with Torin1, containing 1,536 colonies with each mutant printed in quadruplicate. Red boxes indicate three Torin1-resistant mutants.
(F) Torin1 sensitivity test using spotting assays for a WT control and the 19 resistant mutants identified, using different Torin1 concentrations as indicated.
Red frames: 4 mutants showing strong resistance to all Torin1 concentrations tested. (G) Cellular processes associated with the 19 genes (red) required for Torin1-mediated growth inhibition. See also Figure S1 and Table S1 . accumulated in the nucleus within a few minutes following treatment with Torin1 ( Figure 3A ) or with caffeine and rapamycin (Figure S2) , drugs that inhibit TORC1, but not TORC2 . Consistently, Gaf1 is known to translocate to the nucleus during nitrogen limitation, which also inhibits TORC1, and biochemical analyses have shown that Gaf1 localization and phosphorylation depend on TORC1 activity (Laor et al., 2015; Ma et al., 2015) . This regulation of GATA transcription factors is conserved: budding yeast Gln3 and Gat1 (Broach, 2012) and mammalian GATA6 (Xie et al., 2015) are also sequestered in the cytoplasm by active TORC1 and translocate to the nucleus upon TORC1 inhibition. In S. pombe, Gaf1 activates genes functioning in amino-acid transport but represses ste11, encoding a master regulator for meiotic differentiation (Kim et al., 2012; Ma et al., 2015) . To systematically identify Gaf1-dependent transcripts, we performed microarray analyses of wild-type and gaf1D cells, both before and after Torin1 treatment. Before Torin1 treatment, wild-type and gaf1D cells showed similar expression signatures ( Figures 3B and 3C ). We conclude that in proliferating cells, Gaf1 plays no or a negligible role in gene regulation, consistent with its cytoplasmic localization when TORC1 is active ( Figure 3A ; Laor et al., 2015) .
However, Torin1 treatment resulted in substantial transcriptome changes in both wild-type and gaf1D cells, but in gaf1D cells, the expression signature markedly differed from the signature in wild-type cells ( Figures 3B and 3C ). Overall, 90 and 108 genes consistently showed R1.5-fold higher or lower expression, respectively, in gaf1D relative to wild-type cells after Torin1 treatment ( Figure 3B ; Table S2 ). Cells treated with caffeine and rapamycin, which inhibit TORC1, but not TORC2 , showed similar expression signatures as Torin1-treated cells in both wild-type and gaf1D cells ( Figures 3B and 3C ). This result indicates that the Torin1-mediated expression signatures in wild-type and gaf1D cells reflect TORC1 inhibition. We conclude that after TORC1 inhibition, Gaf1 affects the expression of $200 genes, either positively or negatively.
We performed functional enrichment analyses for these Gaf1dependent genes using AnGeLi and g:profiler (Bitton et al., 2015; Raudvere et al., 2019) . The 90 genes that were expressed higher in gaf1D than in wild-type cells (i.e., genes repressed by Gaf1) were typically downregulated in Torin1-treated wild-type cells but less so in gaf1D cells ( Figure 3B ). These genes were enriched in anabolic processes such as biosynthesis (61 genes, p = 9.4 3 10 À10 ), ribosome biogenesis (19 genes, p = 1.6 3 10 À3 ), and cytoplasmic translation (31 genes, p = 1.0 3 10 À16 ), including 25 genes encoding ribosomal proteins. In budding yeast and worms, genetic inhibition of ribosomal proteins leads to lifespan extension (Hansen et al., 2008; McCormick et al., 2015) . Figure S3 visualizes all Gene Ontology (GO) biological processes enriched among the 90 genes. Many of these genes are also repressed as part of the core environmental stress response (43 genes, p = 1.4 3 10 À20 ; Chen et al., 2003) and are highly expressed in proliferating cells (mean of 46.9 mRNA copies/cell versus 7.5 copies for all mRNAs, p = 1.2 3 10 À26 ; Marguerat et al., 2012) . We conclude that upon TORC1 inhibition, Gaf1 contributes to the downregulation of highly expressed genes functioning in protein synthesis.
The 108 genes that were expressed lower in gaf1D than in wild-type cells (i.e., genes induced by Gaf1) were typically upregulated in Torin1-treated wild-type cells but less so in gaf1D cells ( Figure 3B ). These genes were enriched in several metabolic processes of small molecules, including organonitrogen compounds (43 genes, p = 4.6 3 10 À14 ), amino acids (18 genes, p = 4.1 3 10 À5 ), urea (6 genes, p = 7.3 3 10 À5 ), and organic acids (20 genes, p = 0.001) ( Figure S3 ). There was also a substantial overlap with genes that are induced by nitrogen limitation (43 genes, p = 1.3 3 10 À29 ; Mata et al., 2002) and genes that are periodically expressed during the cell cycle (41 genes, p = 1.6 3 10 À12 ; Marguerat et al., 2006) , including 9 histone genes. These results suggest a Gaf1-dependent transcriptional program to adjust the metabolism of amino acids and other molecules, possibly to recycle nutrients under conditions that do not allow rapid proliferation. Similar gene-expression changes are mediated by budding yeast Gln3 and Gat1 under conditions of TORC1 inhibition (Kuroda et al., 2019; Scherens et al., 2006) . Altogether, these findings indicate that Gaf1 regulates physiological changes supporting the growth arrest triggered by TORC1 inhibition.
Gaf1 Binds to Both Coding and tRNA Genes following TOR Inhibition
The microarray analyses identified genes whose expression depends on Gaf1, some of which may be directly regulated by Gaf1. To detect gene promoters bound by Gaf1, we performed chromatin immunoprecipitation sequencing (ChIPseq) of Gaf1-GFP cells. The number of Gaf1-bound promoters increased from 165 before Torin1 treatment to 454 after Torin1 treatment, with 93 genes in common between the two conditions ( Figure 4A ). Gaf1 binding sites upstream of close, divergently expressed genes were assigned to both genes. The Gaf1 target genes after Torin1 treatment consisted of 245 protein-coding genes and 209 non-coding genes (Table S3 ).
The protein-coding Gaf1 target genes were significantly enriched in metabolic processes of organonitrogen compounds (55 genes, p = 1.4 3 10 À6 ), including nucleotides (24 genes, p = 0.0009) and organic acids (34 genes, p = 0.0003) ( Figure S4 ). They were also enriched for genes induced by nitrogen limitation (40 genes, p = 1.6 3 10 À11 ) and periodically expressed during the cell cycle (53 genes, p = 4.5 3 10 À6 ). Overall, these target genes showed similar functional enrichments to the genes whose expression was induced by Gaf1. Accordingly, Gaf1 binding sites were enriched among the genes induced by Gaf1 (Figure 3B , orange bars). Moreover, most protein-coding genes bound by Gaf1 were induced by TORC1 inhibition but less so in gaf1D cells, leading to distinct clusters for wild-type and mutant conditions ( Figure 4B ). We conclude that coding Gaf1 target genes are mostly upregulated by Gaf1 when TORC1 is inhibited.
Notably, Gaf1 bound to the promoters of 20 transcription factor genes (Table S3 ; Figure S4 ). Typically, these factors were induced in wild-type cells after TORC1 inhibition but less so in gaf1D cells. Many of these factors are involved in stress responses or cell-cycle regulation, including Atf1 (Wilkinson et al., 1996) , Cbf12 (Chen et al., 2003) , Fep1 (Bekker et al., 1991) , Fil1 (Duncan et al., 2018) , Hsr1 (Chen et al., 2008) , Klf1 (Shimanuki et al., 2013) , Loz1 (Corkins et al., 2013) , Pap1 (Chen et al., 2008) , Php3 (Mercier et al., 2006) , and Sep1 (Rustici et al., 2004) . These transcription-factor targets indicate that Gaf1 may indirectly control some Gaf1-dependent genes via other transcription factors. Gaf1 inhibited the expression of many genes functioning in translation ( Figure S3 ), but these genes were not among its direct binding targets. These genes may thus be indirectly regulated by Gaf1; for example, Atf1 represses Figure S2. (B) Hierarchical clustering of microarray data. Columns represent WT or gaf1 mutants (gaf1D) before (untreated) and after 1 h of treatment with 20 mM Torin1 or with 10 mM caffeine and 100 ng/mL of rapamycin (Caff+Rap). Rows represent the 198 genes whose mRNA levels changed R1.5-fold in Torin1treated gaf1D cells relative to WT cells, consisting of 90 genes showing higher expression (red bar) and 108 genes showing lower expression (blue bar) in gaf1D cells. In untreated cells, only 3 genes showed R1.5-fold expression changes in gaf1D relative to WT cells. Average RNA expression changes (from 2 independent repeats) in the different genetic and pharmacological conditions relative to WT control cells are color coded as shown. The orange bars indicate 43 genes whose promoters were bound by Gaf1 after 60 min with Torin1. See also Figure S3 . translation-related genes during stress (Chen et al., 2008) , raising the possibility that it also represses these genes during TORC1 inhibition in a Gaf1-dependent manner. The 209 non-coding genes among the Gaf1 targets included 82 tRNA genes and a small nucleolar RNA (snoRNA) involved in tRNA regulation, besides large non-coding RNAs (Table S3 ). Coverage plotting indicated that Gaf1 binds to all tRNA genes that are clustered in S. pombe (Figure 4C; Figure S5 ). Binding occurred near the transcription start sites for tRNA genes and strongly increased after Torin1 treatment ( Figure 4C ). We conclude that Gaf1 binds not only to genes transcribed by RNA Pol II but also to the tRNA genes transcribed by RNA Pol III. To address whether Gaf1 represses or activates tRNAs, we performed northern analyses of tRNA gene expression as a function of Gaf1 and Torin1. The abundant mature tRNAs are rapidly processed from precursor tRNAs, which need to be assayed to detect expression changes (Otsubo et al., 2018) . The expression of tRNA precursors decreased during Torin1 treatment in wildtype cells, while in gaf1D cells their expression was higher and showed a delayed and less pronounced decrease, especially at later time points ( Figures 4D and 4E ). We conclude that Gaf1 binds to tRNA genes and inhibits their expression upon TOR inhibition.
Downregulation of precursor tRNA expression is required for TORC1 inhibition in S. pombe (Otsubo et al., 2018) , indicating that tRNAs can act upstream of TORC1. Our experiments, conversely, point to a mechanism of tRNA regulation downstream of TORC1. Altogether, these findings suggest regulatory feedback, involving precursor tRNAs, TORC1, and Gaf1, to match tRNA expression to physiological requirements. Our results reveal a transcription factor that not only controls RNA Pol II-mediated expression of genes functioning in translation-and metabolism-related processes but also globally inhibits RNA Pol III-mediated expression of tRNAs. It will be interesting to test whether the latter function is conserved for orthologous GATA transcription factors. Studies of Gln3 and Gat1 function in budding yeast have excluded tRNAs and are therefore not conclusive with respect to tRNA gene regulation (Kuroda et al., 2019; Scherens et al., 2006) . (B) Hierarchical clustering of microarray data for 150 protein-coding genes bound by Gaf1 after Torin1 treatment and for which expression data were available for all conditions. The conditions have been clustered as well (red tree on top) and are grouped as follows: untreated WT and gaf1D cells (Uwt, Ugaf1), caffeine+rapamycin-or Torin1-treated gaf1D cells (CRgaf1, Tgaf1), and caf-feine+rapamycin-or Torin1-treated WT cells (CRwt, Twt). Expression changes are color coded as in Figure 3B . (C) Gaf1 shows increased binding to tRNA genes after Torin1 treatment. Top, red curves: average Gaf1 binding profiles aligned to transcription start sites (TSSs) of all S. pombe tRNA genes before (0 min) and after (60 min) Torin1 treatment, along with corresponding control ChIP-seq data (hemagglutinin [HA]). Bottom: heatmaps of Gaf1 binding around the TSS of all 196 tRNAs, ordered by normalized ChIP-seq coverage. See also Figure S5 . (D) Northern blots of precursor tRNAs for leucine (top) and asparagine (middle) from WT and gaf1D cells, treated with 20 mM Torin1 over 120 min as indicated. Probes to detect precursor tRNAs, indicated with red bars, are as described before (Otsubo et al., 2018) . Probes for cdc2 were used as loading control (bottom). (E) Northern quantitation of leucine and asparagine precursor tRNAs relative to WT time 0 and normalized to loading controls (three independent repeats shown as dots). Asterisks denote significant differences in pre-tRNA levels between WT and gaf1D cells from same time point (t test, p < 0.05).
(F) Model for Gaf1-mediated transcriptional repression of translation downstream of TORC1. Following TORC1 inhibition, Gaf1 activates the transcription of genes for small-molecule metabolic pathways and represses the transcription of tRNAs and other genes functioning in translation (the latter via indirect control, hatched). Together with the S6K-mediated translational control (Ma and Blenis, 2009 ), this transcriptional branch contributes to longevity.
Conclusions
The GATA transcription factor Gaf1 is essential for blocking cell proliferation with Torin1; in its absence, cell growth remains normal, even in high doses of Torin1 ( Figure 1G ). Gaf1 is also required for normal chronological lifespan and contributes to, but is not necessary for, the longevity of Torin1-treated cells (Figure 2) . Upon TORC1 inhibition, Gaf1 inhibits the expression of genes functioning in protein translation, including protein-coding genes, which may be indirectly controlled by Gaf1, and tRNA genes, which are binding targets of Gaf1 (Figures 3 and 4 ). Gaf1 also positively controls genes functioning in metabolic pathways for nitrogen-containing molecules, which support the adaptation to lowered protein synthesis. Thus, Gaf1 can directly regulate both RNA Pol II-and RNA Pol III-transcribed genes. It is possible that Gaf1 elicits its repressor activity at tRNA genes by recruiting a histone deacetylase: work in S. pombe has identified potential loading sites for Clr6 complex components at tRNAs (Zilio et al., 2014) . Downregulation of global protein translation is beneficial for longevity in all organisms studied, including S. pombe (Kaeberlein and Kennedy, 2011; . Given its role in repressing diverse translation-related factors, Gaf1 may inhibit aging by contributing to the downregulation of translation upon TORC1 inhibition ( Figure 4F ). Gaf1 thus defines a transcription-based branch of translational and metabolic control downstream of TORC1, in parallel to the post-translational branch exerted by translational regulators like S6K (Figure 4F) . This transcriptional branch is essential for growth inhibition triggered by lowered TORC1 activity. Repression of RNA Pol III prolongs lifespan in yeast, worms, and flies and is required for the lifespan extension mediated by TORC1 inhibition (Filer et al., 2017) . Besides general transcription factors such as TFIIIB, TFIIIC, and TBP, several factors control RNA Pol III transcription without directly binding to DNA (Hummel et al., 2019) , including the RNA Pol III inhibitor Maf1, the coactivator PNRC, and MYC, which interacts with the RNA Pol III basal apparatus (Campbell and White, 2014; Graczyk et al., 2018; Zhou et al., 2007) . To our knowledge, the TORC1 target Gaf1 is the first specific transcription factor shown to globally bind to and repress the tRNA genes. Thus, Gaf1 could exert the aging-associated function of RNA Pol III. Recent work in flies shows that GATA transcription factors can mediate the effects of dietary restriction on lifespan (Dobson et al., 2018) . This finding raises the possibility that Gaf1 regulation of aging-related processes is conserved and that other GATA factors exert similar functions downstream of TORC1. The mouse and human ortholog of Gaf1, GATA6, is involved in differentiation, stem cell maintenance, and cancer (Viger et al., 2008; Wamaitha et al., 2015; Zhong et al., 2011) . It is plausible that GATA6 exerts these important functions by regulating translation-related genes, including tRNAs.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 30 min exposure to FM4-64, cells were washed and chased for 40 min in fresh media to allow all dye to reach the vacuole. Fluorescence microscopy was performed using a Rhodamine filter for detection of FM4-64 and a Hamamatsu ORCA-ER C4742-95 digital camera fitted to a Zeiss Axioskop microscope with EC plan-NEOFLUAR 3 63 1.25 NA oil objective. Images were recorded using the Volocity acquisition program (PerkinElmer). At least 500 vacuoles were measured using the Volocity quantitation package (PerkinElmer). Results were analyzed in R.
Chronological lifespan assay
Cells were grown in EMM2 media as described . When cultures reached a stable maximal density, cells were left an additional 24 hr and then harvested, serially diluted, and incubated on YES plates. The measurement of colony-forming units (CFUs) was taken at the beginning of the lifespan curve (time point 0: 100% cell survival). CFU measurements were conducted on successive days until cultures dropped to 0.1% cell survival. Error bars represent standard deviation calculated from three independent cultures, with each culture measured three times at each time point. To determine the chronological lifespan when TOR is inhibited, 8 mM Torin1 was added to rapidly proliferating cell cultures at OD 600 = 0.5 which were then grown to stationary phase, and lifespan was recorded as described above. AUCs were measured with ImageJ (Schindelin et al., 2012) for all experimental repeats using lifespans curves on the linear scale for % survival.
High-throughput genetic screening
The haploid deletion libraries were plated onto YES plates containing 100 mg/ml G418 using a RoToR HDA robot (Singer). Multiple replicate copies of the library were thus generated. Using the RoToR, the libraries were compacted into nine 384-density plates of plates and then printed onto plates containing 20 mM Torin1. The plates were incubated at 32 C for 2 days and then manually scored for resistant colonies.
was sequenced using Illumina Mi-seq with a V3 kit, sequencing 75 bp on each end. Sequences were aligned to the S. pombe genome build ASM294v2 using Bowtie2. Peak calling was done with GEM (Guo et al., 2012) (setting-k_min 4 and-k_max 18), and peak annotation was done with the R package ChIPpeakAnno (Zhu et al., 2010) . Peaks were annotated to the closest TSS; for peaks lying within 500 bp of 2 divergently expressed genes, peaks were annotated to both genes. Normalizations for the plots were performed using deeptools (Ramírez et al., 2016 ) (normalizing to RPGC and using the parameters -centerReads -binsize 10 -smoothLength 2). Further analyses were carried out with R scripts (http://www.r-project.org/). Gene enrichment analysis was performed using AnGeLi (Bitton et al., 2015) and g:profiler (Raudvere et al., 2019) .
Northern analyses
Detection of tRNA precursors was performed as described (Otsubo et al., 2018) using Digoxigenin labeled probes (Roche), following the manufacturer's instructions. As a loading control, northerns were stripped by incubating for 60 min at 60 C with 0.1% SDS, changing the solution every 10 min, followed by re-hybridizing with a Digoxigenin labeled probe specific for cdc2 (cdc2-SRT GGGCAGGGTCATAAACAAGC) as described (Clé ment-Ziza et al., 2014) . Quantification of Northern blots has been performed by ImageJ (Schindelin et al., 2012) as previously described (Rallis et al., 2014) . Ratios of each tRNA band signal with the corresponding cdc2 loading control have been normalized with the ratio at time point 0 for each tRNA and genotype.
QUANTIFICATION AND STATISTICAL ANALYSIS
Northern blot and lifespan AUC quantification has been conducted using ImageJ using 3 independent biological repeats (n = 3). Significance has been defined using t tests with a p value cutoff of 0.05. Microarray experiments have been conducted in 2 biological repeats with a dye swap. ChIP-seq experiments have been conducted in 2 biological repeats. Quantifications and statistical analysis are also described in corresponding STAR Methods sections. Lifespan assays have been performed in three biological repeats with each time point measured in three technical repeats for each biological replicate. t tests were used for AUC statistics. For Figures S3  and S4 , p values refer to adjusted p values using the g:SCS algorithm described in the g:profiler software (Raudvere et al., 2019) . For Figure 1B , each boxplot represents at least 500 measured vacuoles. In Figure S1 , each boxplot represents at least 100 measured cells.
DATA AND CODE AVAILABILITY

Scripts for Analysis
Scripts, packages and programs used for analyses are mentioned in the main text and listed within the Key Resources Table. Dataset Hosting The accession numbers for the ChIP-seq data reported in this paper are ENA: PRJEB32910 and ERP115647. The accession number for the microarray data reported in this paper is ArrayExpress: E-MTAB-8569. A 125 mg/ml 300 mg/ml 5 mg/ml 25 mg/ml 15 mg/ml 6 Time (hours) 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 Figure S1. Characterization of Torin1-resistant strains, Related to Figure 1. A. Resistance to Torin1 is not a result of multi-drug resistance. Spot assays of wild-type and the 19 resistant mutants in presence of different drugs as indicated. Control mutants that show multi-drug sensitivity are also spotted (vam6Δ, gtr1Δ, gtr2Δ) to show that the drugs are functional. B. Phosphorylation status of ribosomal S6 protein in verified Torin1-resistant mutants in the presence or absence of Torin1 as indicated. C. Cell size upon division of wild-type and resistant mutant cells, before (blue) and after (yellow) Torin1 treatment. Cells were grown in YES liquid medium to mid-exponential phase (OD600 =0.5), when caffeine (10 mM), rapamycin (100 ng/ml), or both drugs combined at same doses were added, and cells were incubated with shaking at 32°C for 30 minutes. Control cells were not exposed to the drugs but otherwise treated the same. Cells were photographed in a Zeiss Axioskop microscope using the Volocity software. All cells showed nuclear localization of Gaf1 after treatment with caffeine or with both drugs; the nuclear translocation of Gaf1 was less efficient in cells treated with rapamycin only, reflecting that rapamycin alone only partially inhibits TORC1 in S. pombe . Figure S3 . Functional enrichments among differentially expressed genes, Related to Figure 3 . Visualization of all GO Biological Process categories enriched among the 108 genes that are repressed (down) and the 90 genes that are induced (up). Gene enrichment analysis was done using g:profiler (https:// academic.oup.com/nar/advance-article/doi/10.1093/nar/gkz369/5486750). Results were plotted using a custom R script. Colors represent -log10 p values for the GO term enrichments. The size of the bubbles represents the ratio between the number of genes in the gene list and the total number of genes in the GO category (in percentage); only terms with p values <0.05 are represented. Figure 4C . Gaf1 binding peaks within Chromosome II region containing clustered tRNA genes (marked in red). Binding profiles are shown for cells before (0 min) and 60 min after treatment with Torin 1 as indicated. Signals from experimental IPs (GFP) are shown in blue, while control IPs (HA) are shown in grey. Table S1 . Torin1-resistant mutants, Related to Figure 1 . List of the 19 mutants that show resistance to Torin1. Mutants with black fonts have previously been shown to be resistant to Torin1. Mutants with red fonts are first reported as Torin1-resistant in this study.
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